Trump vs. big pharma

Chris Meekins, FBR Capital Markets research analyst, and Seamus Fernandez, Leerink Partners managing director & pharma analyst, discuss President-elect Trump's comments on drug pricing and their effect on biotech and pharma stocks....
7 Published By - cnbc.latest - 2017.01.11. 20:19
Share |